Escient Pharmaceuticals Appoints Joshua Grass, MBA as CEO

Escient Pharmaceuticals Appoints Joshua Grass, MBA as CEO

Post Views: 88 -Escient Pharmaceuticals, a clinical-stage company focused on discovering and developing novel, first-in-class therapies to address serious, unserved medical needs, today announced the appointment of Joshua Grass, MBA as Chief Executive Officer effective immediately. Mr. Grass will join the company’s Board of Directors. He succeeds Alain Baron, M.D., who recently retired and will…